13 results on '"De Meyer, D."'
Search Results
2. DEVELOPMENT AND VERIFICATION OF T-TRACE/PANTHER COUPLED CODE
- Author
-
Abarca A., Avramova M., Ivanov K., Verdebout S., De Meyer D., and Schneidesch C. R.
- Subjects
trace ,panther ,coupled codes ,socket communication ,tmi mslb ,Physics ,QC1-999 - Abstract
Multi-physics coupled simulations have become increasingly important during the last two decades being one of the major field of application in the nuclear technology. The nuclear reactors themselves are complex systems whose responses are driven by interactions between neutron kinetics, thermal-hydraulics, heat transfer, mechanics and chemistry. Probably, in a nuclear system, the most complex and important feedback effect takes place between the core neutron kinetics and thermal-hydraulics. The development of coupled thermal-hydraulic -neutron kinetics codes is a recurrent field of research for the nuclear industry. This contribution, developed in the Consortium for Nuclear Power (CNP) framework, has the objective of develop a dynamic coupling, using TCP/IP based socket communication, between the thermal-hydraulic system code T-TRACE, Tractebel-ENGIE version of the latest US NRC TRACE release, and the multi-group 3-D nodal diffusion and core physics code PANTHER, developed and maintained by EDF Energy (UK). As a first step of the development, a fully temporally explicit coupling scheme has been developed between TRACE and PANTHER based on a boundary conditions exchange at the core level at each temporal iteration. The OECD TMI MSLB benchmark has been selected as verification scenario for testing the ongoing developing T-TRACE/PANTHER coupled code. The developed coupled code is benchmarked code-to-code against TRACE/PARCS and T-RELAP5/PANTHER.
- Published
- 2021
- Full Text
- View/download PDF
3. Silicone adhesive multilayer foam dressings as adjuvant prophylactic therapy to prevent hospital-acquired pressure ulcers: a pragmatic noncommercial multicentre randomized open-label parallel-group medical device trial
- Author
-
Fourie, A., Raepsaet, C., Van Damme, N., Manderlier, B., De Meyer, D., Beele, H., Smet, S., Demarré, L., Vossaert, R., de Graaf, R., Verhaeghe, L., Vandergheynst, N., Hendrickx, B., Hanssens, V., Keymeulen, H., Vanderwee, K., Van De Woestijne, J., Verhaeghe, S., Van Hecke, A., Savoye, Isabelle, Harrison, Jillian, Vrijens, France, Hulstaert, Frank, Beeckman, Dimitri, Fourie, A., Raepsaet, C., Van Damme, N., Manderlier, B., De Meyer, D., Beele, H., Smet, S., Demarré, L., Vossaert, R., de Graaf, R., Verhaeghe, L., Vandergheynst, N., Hendrickx, B., Hanssens, V., Keymeulen, H., Vanderwee, K., Van De Woestijne, J., Verhaeghe, S., Van Hecke, A., Savoye, Isabelle, Harrison, Jillian, Vrijens, France, Hulstaert, Frank, and Beeckman, Dimitri
- Abstract
4-5, Background Silicone adhesive multilayer foam dressings are used as adjuvant therapy to prevent hospital-acquired pressure ulcers (PUs). Objectives To determine whether silicone foam dressings in addition to standard prevention reduce the incidence of PUs of category 2 or worse compared with standard prevention alone. Methods This was a multicentre, randomized controlled medical device trial conducted in eight Belgian hospitals. At-risk adult patients were centrally randomized (n = 1633) to study groups based on a 1 : 1 : 1 allocation: experimental groups 1 (n = 542) and 2 (n = 545) – pooled as the treatment group – and the control group (n = 546). The experimental groups received PU prevention according to hospital protocol, and a silicone foam dressing on the relevant body sites. The control group received standard of care. The primary endpoint was the incidence of a new PU of category 2 or worse at the studied body sites. Results In the intention-to-treat population (n = 1605), PUs of category 2 or worse occurred in 4·0% of patients in the treatment group and 6·3% in the control group [relative risk (RR) 0·64, 95% confidence interval (CI) 0·41–0·99, P = 0·04]. Sacral PUs were observed in 2·8% and 4·8% of the patients in the treatment group and the control group, respectively (RR 0·59, 95% CI 0·35–0·98, P = 0·04). Heel PUs occurred in 1·4% and 1·9% of patients in the treatment and control groups, respectively (RR 0·76, 95% CI 0·34–1·68, P = 0·49). Conclusions Silicone foam dressings reduce the incidence of PUs of category 2 or worse in hospitalized at-risk patients when used in addition to standard of care. The results show a decrease for the sacrum, but no statistical difference for the heel and trochanter areas.
- Published
- 2021
4. Silicone adhesive multilayer foam dressings as adjuvant prophylactic therapy to prevent hospital-acquired pressure ulcers : a pragmatic non-commercial multicentre randomised open label parallel group medical device trial
- Author
-
Beeckman, Dimitri, Fourie, A., Raepsaet, C., Van Damme, N., Manderlier, B., De Meyer, D., Beele, H., Smet, S., Demarré, L., Vossaert, R., de Graaf, A., Verhaeghe, L., Vandergheynst, N., Hendrickx, B., Hanssens, V., Keymeulen, H., Vanderwee, K., Van De Woestijne, J., Verhaeghe, S., Van Hecke, A., Savoye, I., Harrison, J., Vrijens, F., Hulstaert, F., Beeckman, Dimitri, Fourie, A., Raepsaet, C., Van Damme, N., Manderlier, B., De Meyer, D., Beele, H., Smet, S., Demarré, L., Vossaert, R., de Graaf, A., Verhaeghe, L., Vandergheynst, N., Hendrickx, B., Hanssens, V., Keymeulen, H., Vanderwee, K., Van De Woestijne, J., Verhaeghe, S., Van Hecke, A., Savoye, I., Harrison, J., Vrijens, F., and Hulstaert, F.
- Abstract
BACKGROUND: Silicone adhesive multilayer foam dressings are used as adjuvant therapy to prevent hospital-acquired pressure ulcers (PUs). OBJECTIVES: Determine if silicone foam dressings in addition to standard prevention reduce PU incidence category 2 or worse compared to standard prevention alone. METHODS: Multicentre, randomised controlled, medical device trial conducted in eight Belgian hospitals. At risk adult patients were centrally randomised (n=1633) to study groups based on a 1:1:1 allocation: experimental group 1 (n=542) and 2 (n=545) - pooled as the treatment group - and the control group (n=546). Experimental groups received PU prevention according to hospital protocol, and a silicone foam dressing on these body sites. The control group received standard of care. The primary endpoint was the incidence of a new PU category 2 or worse at these body sites. RESULTS: In the intention-to-treat population (n=1605); 4.0% of patients developed PUs category 2 or worse in the treatment group and 6.3% in the control group (RR=0.64, 95% CI 0.41 to 0.99, P=0.04). Sacral PUs were observed in 2.8% and 4.8% of the patients in the treatment group and the control group, respectively (RR=0.59, 95% CI 0.35 to 0.98, P=0.04). Heel PUs occurred in 1.4% and 1.9% of patients in the treatment and control group respectively (RR=0.76, 95% CI 0.34 to 1.68, P=0.49). CONCLUSIONS: Silicone foam dressings reduce the incidence of PUs category 2 or worse in hospitalised at-risk patients when used in addition to standard of care. Results show a decrease for sacrum, but no statistical difference for heel/trochanter areas., Funding Agency:Belgian Health Care Knowledge Centre (KCE) KCE16012
- Published
- 2021
- Full Text
- View/download PDF
5. DEVELOPMENT AND VERIFICATION OF T-TRACE/PANTHER COUPLED CODE.
- Author
-
Margulis, M., Blaise, P., Abarca, A., Avramova, M., Ivanov, K., Verdebout, S., De Meyer, D., and Schneidesch, C. R.
- Subjects
THERMAL hydraulics ,BOUNDARY value problems ,NUCLEAR reactors ,NUCLEAR fission ,NEUTRON transport theory - Abstract
Multi-physics coupled simulations have become increasingly important during the last two decades being one of the major field of application in the nuclear technology. The nuclear reactors themselves are complex systems whose responses are driven by interactions between neutron kinetics, thermal-hydraulics, heat transfer, mechanics and chemistry. Probably, in a nuclear system, the most complex and important feedback effect takes place between the core neutron kinetics and thermal-hydraulics. The development of coupled thermal-hydraulic -neutron kinetics codes is a recurrent field of research for the nuclear industry. This contribution, developed in the Consortium for Nuclear Power (CNP) framework, has the objective of develop a dynamic coupling, using TCP/IP based socket communication, between the thermal-hydraulic system code T-TRACE, Tractebel-ENGIE version of the latest US NRC TRACE release, and the multi-group 3-D nodal diffusion and core physics code PANTHER, developed and maintained by EDF Energy (UK). As a first step of the development, a fully temporally explicit coupling scheme has been developed between TRACE and PANTHER based on a boundary conditions exchange at the core level at each temporal iteration. The OECD TMI MSLB benchmark has been selected as verification scenario for testing the ongoing developing T-TRACE/PANTHER coupled code. The developed coupled code is benchmarked code-to-code against TRACE/PARCS and T-RELAP5/PANTHER. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. PROTECT - Trial : A cluster RCT to study the effectiveness of a repositioning aid and tailored repositioning to increase repositioning compliance
- Author
-
De Meyer, D., Van Hecke, A., Verhaeghe, S., Beeckman, Dimitri, De Meyer, D., Van Hecke, A., Verhaeghe, S., and Beeckman, Dimitri
- Abstract
AIM: To study the effectiveness of tailored repositioning and a turning and repositioning system on: (1) nurses' compliance to repositioning frequencies; (2) body posture of patients after repositioning; (3) incidence of pressure ulcers and incontinence-associated dermatitis; (4) nurses' and patients' preferences, comfort and acceptability; and (5) budget impact. BACKGROUND: Patient-tailored systematic repositioning is key in pressure ulcer prevention. To date, a clinical decision-making tool is lacking and compliance to pressure ulcer prevention guidelines is low. Research concerning commercially available turning and repositioning systems is lacking. DESIGN: Multicentre, cluster, three-arm, randomised, controlled pragmatic trial. METHODS: Two hundred twenty-seven patients at risk of pressure ulcer development were recruited at 29 wards in 16 hospitals between February 2016 - December 2017. Wards were randomly assigned to two experimental groups and one control group. RESULTS: Nurses' compliance to repositioning frequencies increased significantly in the experimental groups when patients were cared for in bed (94.6% versus 69% and 84.9% versus 71.4%). Applying the turning and repositioning system was associated with significantly more correctly positioned patients (30-45° tilted side-lying position) (69.6% versus 34.6%). Few pressure ulcers and incontinence-associated dermatitis incidents occurred. Both patients and nurses were positive about the intervention. Higher labour costs related to repositioning in bed were found in the control group. CONCLUSION: This was the first study investigating the effect of tailored repositioning and the use of a repositioning aid to increase nurses' compliance to repositioning. The results were in favour of the interventions yet demonstrating the importance of follow-up and education., Funding Agency:Sage Products LLC Cary Illinois USA
- Published
- 2019
- Full Text
- View/download PDF
7. Stalkimaatparameters monitoren bij vleesvarkens
- Author
-
Klinkenberg, M., Maas, D., Vrielinck, L., De Meyer, D., Klinkenberg, M., Maas, D., Vrielinck, L., and De Meyer, D.
- Abstract
In dit artikel belichten we de voorlopige resultaten van het Europese project Prohealth, waarin onder meer wordt gecheckt in welke mate een combinatie van verschillende klimaatparameters in de stal invloed kan hebben op de diergezondheid.
- Published
- 2016
8. Silicone adhesive multilayer foam dressings as adjuvant prophylactic therapy to prevent hospital-acquired pressure ulcers: a pragmatic noncommercial multicentre randomized open-label parallel-group medical device trial
- Author
-
Beeckman, Dimitri, Fourie, A., Raepsaet, C., Van Damme, N., Manderlier, B., De Meyer, D., Beele, H., Smet, S., Demarré, L., Vossaert, R., de Graaf, R., Verhaeghe, L., Vandergheynst, N., Hendrickx, B., Hanssens, V., Keymeulen, H., Vanderwee, K., Van De Woestijne, J., Verhaeghe, S., Van Hecke, A., Savoye, Isabelle, Harrison, Jillian, Vrijens, France, and Hulstaert, Frank
- Subjects
Pressure Ulcer ,Journal Article ,prevention and control ,W 1 Serials. Periodicals - Abstract
4-5 Background Silicone adhesive multilayer foam dressings are used as adjuvant therapy to prevent hospital-acquired pressure ulcers (PUs). Objectives To determine whether silicone foam dressings in addition to standard prevention reduce the incidence of PUs of category 2 or worse compared with standard prevention alone. Methods This was a multicentre, randomized controlled medical device trial conducted in eight Belgian hospitals. At-risk adult patients were centrally randomized (n = 1633) to study groups based on a 1 : 1 : 1 allocation: experimental groups 1 (n = 542) and 2 (n = 545) – pooled as the treatment group – and the control group (n = 546). The experimental groups received PU prevention according to hospital protocol, and a silicone foam dressing on the relevant body sites. The control group received standard of care. The primary endpoint was the incidence of a new PU of category 2 or worse at the studied body sites. Results In the intention-to-treat population (n = 1605), PUs of category 2 or worse occurred in 4·0% of patients in the treatment group and 6·3% in the control group [relative risk (RR) 0·64, 95% confidence interval (CI) 0·41–0·99, P = 0·04]. Sacral PUs were observed in 2·8% and 4·8% of the patients in the treatment group and the control group, respectively (RR 0·59, 95% CI 0·35–0·98, P = 0·04). Heel PUs occurred in 1·4% and 1·9% of patients in the treatment and control groups, respectively (RR 0·76, 95% CI 0·34–1·68, P = 0·49). Conclusions Silicone foam dressings reduce the incidence of PUs of category 2 or worse in hospitalized at-risk patients when used in addition to standard of care. The results show a decrease for the sacrum, but no statistical difference for the heel and trochanter areas.
- Published
- 2021
9. The role of Helicobacter suis, Fusobacterium gastrosuis, and the pars oesophageal microbiota in gastric ulceration in slaughter pigs receiving meal or pelleted feed.
- Author
-
Taillieu E, Taelman S, De Bruyckere S, Goossens E, Chantziaras I, Van Steenkiste C, Yde P, Hanssens S, De Meyer D, Van Criekinge W, Stock M, Maes D, Chiers K, and Haesebrouck F
- Subjects
- Animals, Swine, RNA, Ribosomal, 16S, Gastric Mucosa, Stomach Ulcer microbiology, Stomach Ulcer pathology, Stomach Ulcer veterinary, Helicobacter heilmannii, Swine Diseases microbiology, Helicobacter Infections veterinary, Helicobacter Infections microbiology, Microbiota, Fusobacterium
- Abstract
This study investigated the role of causative infectious agents in ulceration of the non-glandular part of the porcine stomach (pars oesophagea). In total, 150 stomachs from slaughter pigs were included, 75 from pigs that received a meal feed, 75 from pigs that received an equivalent pelleted feed with a smaller particle size. The pars oesophagea was macroscopically examined after slaughter. (q)PCR assays for H. suis, F. gastrosuis and H. pylori-like organisms were performed, as well as 16S rRNA sequencing for pars oesophagea microbiome analyses. All 150 pig stomachs showed lesions. F. gastrosuis was detected in 115 cases (77%) and H. suis in 117 cases (78%), with 92 cases (61%) of co-infection; H. pylori-like organisms were detected in one case. Higher infectious loads of H. suis increased the odds of severe gastric lesions (OR = 1.14, p = 0.038), while the presence of H. suis infection in the pyloric gland zone increased the probability of pars oesophageal erosions [16.4% (95% CI 0.6-32.2%)]. The causal effect of H. suis was mediated by decreased pars oesophageal microbiome diversity [-1.9% (95% CI - 5.0-1.2%)], increased abundances of Veillonella and Campylobacter spp., and decreased abundances of Lactobacillus, Escherichia-Shigella, and Enterobacteriaceae spp. Higher infectious loads of F. gastrosuis in the pars oesophagea decreased the odds of severe gastric lesions (OR = 0.8, p = 0.0014). Feed pelleting had no significant impact on the prevalence of severe gastric lesions (OR = 1.72, p = 0.28). H. suis infections are a risk factor for ulceration of the porcine pars oesophagea, probably mediated through alterations in pars oesophageal microbiome diversity and composition., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
10. Effect of Pig Synthetic Pheromones and Positive Handling of Pregnant Sows on the Productivity of Nursery Pigs.
- Author
-
De Meyer D, Chantziaras I, Amalraj A, and Maes D
- Abstract
Weaning is one of the most important stress events in the life of pigs, increasing the risk for health problems and reduced performance. The release of pheromones in pig stables can be considered an environmental enrichment and alleviate the negative effects of weaning stress in nursery pigs. The present study investigated the effect of synthetic pheromones on the performance of nursery pigs. The effect of positive handling of sows in the farrowing house on the performance of the offspring in the nursery was also investigated. The study was performed in a commercial pig farm and included 24 batches of weaned piglets (216 piglets per batch). Half of the batches originated from sows exposed to positive handling. This implied that music was played from 6.00 a.m. to 6.00 p.m. from the moment the sows entered the farrowing house until weaning and that they were subjected to backscratching from the day they entered the farrowing unit the day of farrowing. During the nursery period, half of the batches were treated, and half served as controls. Piglets of treated groups were exposed to a synthetic analog of the maternal pig appeasing pheromone (PAP) (SecurePig
® , Signs, Avignon, France). The product consisted of a gel block from which the pheromones were slowly released into the room. Different performance parameters were measured during the nursery period. Neither the sow treatment nor the treatment with pheromones significantly influenced the performance of the piglets during the nursery period ( p > 0.05). The median values (95% confidence interval) of average daily gain, namely 318 (282-338) vs. 305 (272-322) g/day, feed conversion ratio, namely 1.64 (1.51-1.71) vs. 1.70 (1.57-1.75), and number of antimicrobial treatment days, namely 16.9 (9.6-25.0) vs. 17.3 (9.5-25.0) days, were numerically better in the nursery pigs exposed to the pheromones compared to the control groups. Mortality however was numerically higher in the treated groups, namely 4.4 (2.8-6.8) vs. 3.2 (0.9-4.2)%. Under the conditions of the present production system, pigs exposed to the pheromone treatment during the nursery did not show a significant performance increase.- Published
- 2024
- Full Text
- View/download PDF
11. Economic feasibility of interventions targeted at decreasing piglet perinatal and pre-weaning mortality across European countries.
- Author
-
Stygar AH, Chantziaras I, Maes D, Aarestrup Moustsen V, De Meyer D, Quesnel H, Kyriazakis I, and Niemi JK
- Abstract
Background: Piglet perinatal and pre-weaning mortality is a welfare problem causing economic losses in pig production. In this study, the effects of housing and management interventions on the economic result of sow enterprises representing six European countries (Belgium, Denmark, Finland, Germany, The Netherlands and Spain) were tested. Interventions concerned: (1) installing mechanical ventilation, (2) re-designing of the gestation unit, (3) drying and warming newborn piglets, (4) providing enrichment for gestating sows, including high-fiber dietary supplementation and point-source objects, and (5) music provision and backscratching of sows in the farrowing unit. A bio-economic model was used to determine the effects of interventions on economic outcomes during the nursery phase and to calculate a maximum cost of 1%-point reduction in perinatal and pre-weaning mortality, irrespective of the intervention type. Biological parameters were set according to previous observational and experimental studies. Interventions 1-4 were expected to decrease perinatal mortality, defined as stillbirths and deaths occurring within the first 48 h of postnatal life. Intervention 5 was expected to decrease pre-weaning mortality. Interventions increased fixed (1-3) and variable costs (3-5). We hypothesized that housing and management interventions would have a positive economic effect., Results: Piglet mortality can be decreased in various ways. Interventions concerning ventilation and re-designing of the gestation unit (1 and 2) were the most beneficial in countries with low housing costs and high perinatal mortality. Drying and warming newborn piglets (3) resulted in varying economic results, with the highest increase in profits obtained in a country with low labor costs and high litter size. Interventions providing sows with enrichment and human-animal interaction (4 and 5) were effective across varying conditions. Regardless of intervention type, policies aiming at 1%-point reduction in perinatal and pre-weaning mortality could cost from €0.2 to €0.5 (average €0.4) and from €0.4 to €0.5 (average €0.5) per piglet, respectively, depending on productions conditions., Conclusions: To decrease piglet mortality, farmers should consider low input interventions, such as those targeting appropriate behavior. Our results suggest that providing enrichment or increasing human-animal interaction pays off and brings positive economic result even when piglet mortality is marginally reduced., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
12. Independent risk factors for the development of skin erosion due to incontinence (incontinence-associated dermatitis category 2) in nursing home residents: results from a multivariate binary regression analysis.
- Author
-
Van Damme N, Van den Bussche K, De Meyer D, Van Hecke A, Verhaeghe S, and Beeckman D
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Multivariate Analysis, Regression Analysis, Risk Factors, Dermatitis etiology, Dermatitis therapy, Fecal Incontinence complications, Homes for the Aged statistics & numerical data, Nursing Homes statistics & numerical data, Skin Care methods, Urinary Incontinence complications
- Abstract
The aim of this study was to identify characteristics independently associated with a higher risk of developing skin damage because of incontinence [incontinence-associated dermatitis (IAD) category 2] in nursing home residents. As part of a larger randomised controlled trial, IAD incidence was monitored for 1 month in a sample of 381 incontinent residents using a validated IAD Severity Categorisation Tool. Data on demographical, physical, functional and psychological characteristics were collected. The overall IAD incidence (category 1-2) was 30·0%, and 6% of the participants developed skin damage (IAD category 2). Residents who developed IAD category 2 were less mobile [odds ratio (OR) 2·72, 95% confidence interval (CI) 1·06-6·94], had more friction and shear issues (OR 2·54; 95% CI 1·02-6·33) and had more erythema due to incontinence (OR 3·02; 95% CI 1·04-8·73) before IAD category 2 occurrence. Care providers should give full attention to risk factors to both detect residents at risk for IAD development and to start prevention in time., (© 2016 Medicalhelplines.com Inc and John Wiley & Sons Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
13. Interventions for preventing and treating incontinence-associated dermatitis in adults.
- Author
-
Beeckman D, Van Damme N, Schoonhoven L, Van Lancker A, Kottner J, Beele H, Gray M, Woodward S, Fader M, Van den Bussche K, Van Hecke A, De Meyer D, and Verhaeghe S
- Subjects
- Administration, Topical, Adult, Amitriptyline administration & dosage, Dermatitis etiology, Dermatitis prevention & control, Humans, Petrolatum administration & dosage, Randomized Controlled Trials as Topic, Skin Care methods, Skin Cream administration & dosage, Soaps administration & dosage, Zinc Oxide administration & dosage, Dermatitis therapy, Dermatologic Agents administration & dosage, Fecal Incontinence complications, Urinary Incontinence complications
- Abstract
Background: Incontinence-associated dermatitis (IAD) is one of the most common skin problems in adults who are incontinent for urine, stool, or both. In practice, products and procedures are the same for both prevention and treatment of IAD., Objectives: The objective of this review was to assess the effectiveness of various products and procedures to preventand treat incontinence-associated dermatitis in adults., Search Methods: We searched the Cochrane Incontinence Group Specialised Trials Register, which contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, MEDLINE In-Process, MEDLINE Epub Ahead of Print, CINAHL, ClinicalTrials.gov, WHO ICTRP and handsearching of journals and conference proceedings (searched 28 September 2016). Additionally we searched other electronic databases: CENTRAL(2015, Issue 4), MEDLINE (January 1946 to May Week 3 2015), MEDLINE In-Process (inception to 26 May 2015), CINAHL(December 1981 to 28 May 2015), Web of Science (WoS; inception to 28 May 2015) and handsearched conference proceedings (to June 2015) and the reference lists of relevant articles, and contacted authors and experts in the field., Selection Criteria: We selected randomised controlled trials (RCTs) and quasi-RCTs, performed in any healthcare setting, with included participants over 18 years of age, with or without IAD. We included trials comparing the (cost) effectiveness of topical skin care products such as skin cleansers, moisturisers, and skin protectants of different compositions and skin care procedures aiming to prevent and treat IAD., Data Collection and Analysis: Two review authors independently screened titles, abstracts and full-texts, extracted data, and assessed the risk of bias of the included trials., Main Results: We included 13 trials with 1295 participants in a qualitative synthesis. Participants were incontinent for urine, stool, or both, and were residents in a nursing home or were hospitalised.Eleven trials had a small sample size and short follow-up periods. .The overall risk of bias in the included studies was high. The data were not suitable for meta-analysis due to heterogeneity in participant population, skin care products, skin care procedures, outcomes, and measurement tools.Nine trials compared different topical skin care products, including a combination of products. Two trials tested a structured skin care procedure. One trial compared topical skin care products alongside frequencies of application. One trial compared frequencies of application of topical skin care products.We found evidence in two trials, being of low and moderate quality, that soap and water performed poorly in the prevention and treatment of IAD (primary outcomes of this review). The first trial indicated that the use of a skin cleanser might be more effective than the use of soap and water (risk ratio (RR) 0.39, 95% confidence interval (CI) 0.17 to 0.87; low quality evidence). The second trial indicated that a structured skin care procedure, being a washcloth with cleansing, moisturising, and protecting properties, might be more effective than soap and water (RR 0.31, 95% CI 0.12 to 0.79; moderate quality evidence). Findings from the other trials, all being of low to very low quality, suggest that applying a leave-on product (moisturiser, skin protectant, or a combination) might be more effective than not applying a leave-on product. No trial reported on the third primary outcome 'number of participants not satisfied with treatment' or on adverse effects., Authors' Conclusions: Little evidence, of very low to moderate quality, exists on the effects of interventions for preventing and treating IAD in adults. Soap and water performed poorly in the prevention and treatment of IAD. Application of leave-on products (moisturisers, skin protectants, or a combination) and avoiding soap seems to be more effective than withholding these products. The performance of leave-on products depends on the combination of ingredients, the overall formulation and the usage (e.g. amount applied). High quality confirmatory trials using standardised, and comparable prevention and treatment regimens in different settings/regions are required. Furthermore, to increase the comparability of trial results, we recommend the development of a core outcome set, including validated measurement tools. The evidence in this review is current up to 28 September 2016.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.